Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising prevalence of chronic diseases, and cost-saving initiatives from governments and third-party payers. Catalyzed by these factors, the market is expected ... Read More
-
Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of ... Read More
-
Global Biobetters Market - 2023-2030
... global biobetters market is exhibiting at a CAGR of 8.5% during the forecast period (2023-2030). The market trends of biobetters are PEGylation fusion proteins, EKylation, XTEN technology, Pasylation, and so on. Fusion proteins are created ... Read More
-
Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type
... CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from ... Read More
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
-
Haptic Technology Market by Feedback Type (Tactile, Force), Component (Hardware (Actuators, Drivers & Microcontrollers) Software), Application (Consumer Devices, Automotive & Transportation, Commercial & Industrial) and Region - Global Forecast to 2028
... is projected to reach USD 5.0 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 3.7% from 2023 to 2028. The major factors driving the market growth of the haptic technology ... Read More
-
Global Biosimilars Market Report and Forecast 2023-2031
... during the forecast period of 2023-2031, likely to attain a value of USD 105.1 billion by 2031. Biosimilars Market: Introduction and Application Biosimilars are biological products that are highly similar to an already approved and ... Read More
-
2023 Global: Biosimilar Contract Manufacturing - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Landscape & Forecast, 2019–2029 North America Human Insulin Drugs Market Size Grows Steadily to Touch USD 10.3 Billion by 2029 North America human insulin drugs market is flourishing because of an increasing prevalence of type ... Read More
-
Global Rituximab Biosimilars Market Report and Forecast 2023-2031
... of 15.7% during the forecast period of 2023-2031 to reach a value of USD 7.62 billion by 2031. The market growth can be attributed to the increasing prevalence of autoimmune diseases, cancer, and the rising ... Read More
-
Global Pegfilgrastim Biosimilars Market Report and Forecast 2023-2031
... of 7% during the forecast period of 2023-2031. The market growth can be attributed to the increasing prevalence of cancer, a growing geriatric population, and the rising demand for affordable cancer therapies. Global Pegfilgrastim Biosimilars ... Read More
-
Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred tank, Bubble column), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines), End User (Pharma, Biotech, CROs, CMOs) & Region - Global Forecast to 2028
... as lower operational complexity of single-use bioreactors compared to conventional bioreactors, increasing adoption of single-use bioreactors among startups and SMEs, low water and energy consumption among others are expected to provide growth to the market. ... Read More
-
Global Innovative Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Innovative Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Monoclonal Antibody Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Monoclonal Antibody Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Global Biosimilars Drug Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Biosimilars Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global Insulin Biologics and Biosimilars Market Growth (Status and Outlook) 2023-2029
... expected to grow at a CAGR of % from 2023 to 2029. United States market for Insulin Biologics and Biosimilars is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Global Rare Diseases Treatment Market Size study & Forecast, by Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic disorders, Endocrine disorders, Others) by Route of Administration (Oral, Injectable, Others), by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029 Global Rare Diseases Treatment Market is valued at approximately USD 119.6 billion in 2021 and ... Read More
-
PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia,
... User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 Market Overview: The global PEGylated proteins market size reached US$ 1.16 Billion in 2022. Looking forward, IMARC Group expects the ... Read More
-
Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and ... Read More
-
Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 35,993 Million by 2028, exhibiting a growth rate (CAGR) of 20.41% during 2023-2028. The European biosimilar market represents the most mature in the world and continues to rally momentum. This market is expected to grow ... Read More
-
Global Interferon Alpha-2b Biosimilar Market Growth 2023-2029
... comprehensive analysis by region and market sector of projected Interferon Alpha-2b Biosimilar sales for 2023 through 2029. With Interferon Alpha-2b Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed ... Read More
-
Global Interferon Biosimilar Market Growth 2023-2029
... region and market sector of projected Interferon Biosimilar sales for 2023 through 2029. With Interferon Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of ... Read More
-
Global Remicade Biosimilar Market Growth 2023-2029
... research report, the “Remicade Biosimilar Industry Forecast” looks at past sales and reviews total world Remicade Biosimilar sales in 2022, providing a comprehensive analysis by region and market sector of projected Remicade Biosimilar sales for ... Read More
-
US Public Health Spending on Biosimilars: a data driven analysis
... and patients. By the end of 2020, the FDA had approved 29 biosimilar products for eight different original biologic products. Of these, 18 had been launched by the end of that year with many more ... Read More
-
U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030
... & CRO Market Growth & Trends The U.S. biopharmaceutical CMO & CRO market size is expected to reach USD 16.7 billion by 2030, expanding at a CAGR of 6.1% during the forecast period, according to ... Read More
Research Assistance
